Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.

Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H, Murakami T, Manita M, Tabata K, Ooie T, Tatsukawa Y, Sakai H, Yamaki M, Murakami M, Takada T, Osaka Y, Ono Y, Handa K, Sugiyama K, Yoshizawa T, Fukaya H, Tashiro H, Takase S, Harada M, Watanabe E, Yamane T, Yamashita S, Aonuma K.

J Thromb Thrombolysis. 2019 May;47(4):487-494. doi: 10.1007/s11239-019-01835-8.

PMID:
30955142
2.

Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study.

Kawai M, Harada M, Motoike Y, Koshikawa M, Ichikawa T, Watanabe E, Ozaki Y.

Int J Cardiol Heart Vasc. 2019 Jan 17;22:111-116. doi: 10.1016/j.ijcha.2019.01.002. eCollection 2019 Mar.

3.

Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.

Naruse H, Ishii J, Takahashi H, Kitagawa F, Nishimura H, Kawai H, Muramatsu T, Harada M, Yamada A, Motoyama S, Matsui S, Hayashi M, Sarai M, Watanabe E, Izawa H, Ozaki Y.

Crit Care. 2018 Aug 18;22(1):197. doi: 10.1186/s13054-018-2120-z.

4.

Left Atrial Appendage Thrombus Prior to Atrial Fibrillation Ablation in the Era of Direct Oral Anticoagulants.

Harada M, Koshikawa M, Motoike Y, Ichikawa T, Sugimoto K, Watanabe E, Ozaki Y.

Circ J. 2018 Oct 25;82(11):2715-2721. doi: 10.1253/circj.CJ-18-0398. Epub 2018 Aug 11.

5.

Serum microRNA-126 and -223 as new-generation biomarkers for sarcoidosis in patients with heart failure.

Fujiwara W, Kato Y, Hayashi M, Sugishita Y, Okumura S, Yoshinaga M, Ishiguro T, Yamada R, Ueda S, Harada M, Naruse H, Ishii J, Ozaki Y, Izawa H.

J Cardiol. 2018 Dec;72(6):452-457. doi: 10.1016/j.jjcc.2018.06.004. Epub 2018 Jul 24.

PMID:
30054123
6.

Metabolic Considerations in Atrial Fibrillation - Mechanistic Insights and Therapeutic Opportunities.

Harada M, Melka J, Sobue Y, Nattel S.

Circ J. 2017 Nov 24;81(12):1749-1757. doi: 10.1253/circj.CJ-17-1058. Epub 2017 Oct 24. Review.

7.

Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).

Sobue Y, Watanabe E, Lip GYH, Koshikawa M, Ichikawa T, Kawai M, Harada M, Inamasu J, Ozaki Y.

Heart Vessels. 2018 Apr;33(4):403-412. doi: 10.1007/s00380-017-1073-5. Epub 2017 Oct 24.

PMID:
29067492
8.

Multiple-wavelength neutron holography with pulsed neutrons.

Hayashi K, Ohoyama K, Happo N, Matsushita T, Hosokawa S, Harada M, Inamura Y, Nitani H, Shishido T, Yubuta K.

Sci Adv. 2017 Aug 18;3(8):e1700294. doi: 10.1126/sciadv.1700294. eCollection 2017 Aug.

9.

Midkine Promotes Atherosclerotic Plaque Formation Through Its Pro-Inflammatory, Angiogenic and Anti-Apoptotic Functions in Apolipoprotein E-Knockout Mice.

Takemoto Y, Horiba M, Harada M, Sakamoto K, Takeshita K, Murohara T, Kadomatsu K, Kamiya K.

Circ J. 2017 Dec 25;82(1):19-27. doi: 10.1253/circj.CJ-17-0043. Epub 2017 Aug 5.

10.

Prognostic Value of Combination of Plasma D-Dimer Concentration and Estimated Glomerular Filtration Rate in Predicting Long-Term Mortality of Patients With Stable Coronary Artery Disease.

Naruse H, Ishii J, Takahashi H, Kitagawa F, Okuyama R, Kawai H, Muramatsu T, Harada M, Yamada A, Motoyama S, Matsui S, Hayashi M, Sarai M, Watanabe E, Izawa H, Ozaki Y.

Circ J. 2017 Sep 25;81(10):1506-1513. doi: 10.1253/circj.CJ-16-1272. Epub 2017 May 25.

11.

Intracellular Angiotensin-II Interacts With Nuclear Angiotensin Receptors in Cardiac Fibroblasts and Regulates RNA Synthesis, Cell Proliferation, and Collagen Secretion.

Tadevosyan A, Xiao J, Surinkaew S, Naud P, Merlen C, Harada M, Qi X, Chatenet D, Fournier A, Allen BG, Nattel S.

J Am Heart Assoc. 2017 Apr 5;6(4). pii: e004965. doi: 10.1161/JAHA.116.004965.

12.

Physically triggered Takotsubo cardiomyopathy has a higher in-hospital mortality rate.

Sobue Y, Watanabe E, Ichikawa T, Koshikawa M, Yamamoto M, Harada M, Ozaki Y.

Int J Cardiol. 2017 May 15;235:87-93. doi: 10.1016/j.ijcard.2017.02.090. Epub 2017 Feb 23.

PMID:
28262347
13.

Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.

Okuyama R, Ishii J, Takahashi H, Kawai H, Muramatsu T, Harada M, Yamada A, Motoyama S, Matsui S, Naruse H, Sarai M, Hasegawa M, Watanabe E, Suzuki A, Hayashi M, Izawa H, Yuzawa Y, Ozaki Y.

Heart Vessels. 2017 Jul;32(7):880-892. doi: 10.1007/s00380-017-0948-9. Epub 2017 Feb 2.

PMID:
28154958
14.

Assessment of trough rivaroxaban concentrations on markers of coagulation activation in nonvalvular atrial fibrillation population.

Kitagawa F, Ishii J, Hiramitsu S, Takahashi H, Okuyama R, Kawai H, Muramatsu T, Harada M, Motoyama S, Naruse H, Matsui S, Sarai M, Hayashi M, Watanabe E, Izawa H, Ozaki Y.

Heart Vessels. 2017 May;32(5):609-617. doi: 10.1007/s00380-016-0912-0. Epub 2016 Oct 28.

PMID:
27796530
15.

Prognostic Importance of Novel Oxygen Desaturation Metrics in Patients With Heart Failure and Central Sleep Apnea.

Watanabe E, Kiyono K, Matsui S, Somers VK, Sano K, Hayano J, Ichikawa T, Kawai M, Harada M, Ozaki Y.

J Card Fail. 2017 Feb;23(2):131-137. doi: 10.1016/j.cardfail.2016.09.004. Epub 2016 Sep 9.

16.

QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.

Sobue Y, Harada M, Koshikawa M, Ichikawa T, Yamamoto M, Okuda K, Kato Y, Sarai M, Watanabe E, Ozaki Y.

Heart Rhythm. 2015 Dec;12(12):2499-507. doi: 10.1016/j.hrthm.2015.09.008. Epub 2015 Sep 8.

PMID:
26362576
17.

Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression.

Harada M, Tadevosyan A, Qi X, Xiao J, Liu T, Voigt N, Karck M, Kamler M, Kodama I, Murohara T, Dobrev D, Nattel S.

J Am Coll Cardiol. 2015 Jul 7;66(1):47-58. doi: 10.1016/j.jacc.2015.04.056.

18.

Role of inflammation in atrial fibrillation pathophysiology and management.

Harada M, Van Wagoner DR, Nattel S.

Circ J. 2015;79(3):495-502. doi: 10.1253/circj.CJ-15-0138. Epub 2015 Feb 16. Review.

19.

Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling.

Qi XY, Huang H, Ordog B, Luo X, Naud P, Sun Y, Wu CT, Dawson K, Tadevosyan A, Chen Y, Harada M, Dobrev D, Nattel S.

Circ Res. 2015 Feb 27;116(5):836-45. doi: 10.1161/CIRCRESAHA.116.305326. Epub 2015 Jan 21.

PMID:
25608527
20.

Exogenous midkine administration prevents cardiac remodeling in pacing-induced congestive heart failure of rabbits.

Harada M, Hojo M, Kamiya K, Kadomatsu K, Murohara T, Kodama I, Horiba M.

Heart Vessels. 2016 Jan;31(1):96-104. doi: 10.1007/s00380-014-0569-5. Epub 2014 Aug 26.

PMID:
25155308

Supplemental Content

Loading ...
Support Center